MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis

Abstract

A trophy of corpus callosum (C C) related to axonal loss has previously been observed in patients at the early stage of clinically definite multiple sclerosis (CDMS). Atrophy increases with the progression of the disease. Nevertheless, no data concerning the onset of atrophy of C C are currently available. The purpose of this study is to determine if damage in callosal tissue was present at the earliest stage of MS, in a subgroup of patients presenting with a clinically isolated syndrome suggestive of MS (C ISSMS), fulfilling the dissemination in space criteria according to McDonald. Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques were applied to measure C C volume, magnetization transfer ratio (MTR), mean diffusivity (MD), N-acetyl aspartate/choline-containing compounds (NAA/C ho) ratio, N-acetyl aspartate/total creatine (NA A/C r) ratio and C ho/C r ratio inside the C C of 46 C ISSMS patients and 24 sexand age-matched controls. No atrophy of C C was observed in the C ISSMS group. C C of patients was character ized by decreased MTR and increased MD. No change in the NA A/C r ratio was observed while the NA A/C ho ratio decreased and C ho/C r ratio increased in the splenium and the central anterio r part of C C. These abnormalities were present in patients with, but also without, macroscopic lesions inside the C C. O ur results indicate that diffuse structural and metabolic changes, which may be interpreted as representing predominantly myelin patho logy, occur in the C C at the earliest stage of MS before any atrophy is detected.

Keywords

clinically iso lated syndrome suggestive of multiple sclerosis diffusion-weighted and magnetization transfer-weighted MRI magnetic resonance spectroscopic imaging

Get full access to this article

View all access options for this article.

References

Barnard RO , Trigg M. Corpus callosum in multiple sclerosis . J Neurol Neurosurg Psychiatry 1974; 37: 1259-1264 .

Simon JH , Schiffer RB , Rudick RA , Herndon RM. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging . AJNR Am J Neuroradiol 1987; 8: 599-604 .

Simon JH et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR . Radiology 1986; 160: 363-367 .

Dietemann JL et al. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data . Neuroradiology 1988; 30: 478-480 .

Gean-Marton AD et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis . Radiology 1991; 180: 215-221 .

Palmer S , Bradley WG , Chen DY , Patel S. Subcallosal striations: early findings of multiple sclerosis on sagittal, thin-section, fast FLAIR MR images . Radiology 1999; 210: 149-153 .

Rao SM et al. Cerebral disconnection in multiple sclerosis: relationship to atrophy of the corpus callosum . Arch Neurol 1989; 46: 918-920 .

Pozzilli C et al. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis . Cortex 1991; 27: 441-445 .

Pozzilli C et al. Relationship between corpus callosum atrophy and cerebral metabolic asymetries in multiple sclerosis . J Neurol Sci 1992; 112: 51-57 .

10.

Barkhof FJ et al. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients: a preliminary MRI study . J Neurol 1998; 245: 153-158 .

11.

Pelletier J et al. Functional and MRI correlates of callosal involvement in multiple sclerosis . Arch Neurol 1993; 50: 1077-1082 .

12.

Pelletier J et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis . Arch Neurol 2001; 58: 105-111 .

13.

Evangelou N et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis . Brain 2000; 123: 1845-1849 .

14.

McDonald WI et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

15.

Tintore M et al. Isolated demyelinating syndromes: comparaison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS . Mult Scler 2001; 7: 359-363 .

16.

Barkhof F et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis . Brain 1997; 120: 2059-2069 .

17.

Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

18.

Galanaud D et al. Regional metabolite levels of normal posterior fossa studied by proton chemical shift imaging . Magn Reson Phys Biol Med MAGMA 2001; 13: 127-133 .

19.

Von Kienlin M et al. 2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas in rat brain . Magn Reson Med 2000; 43: 211-219 .

20.

Matson G. An integrated program for amplitude-modulatedRF pulse generation and re-mapping with shaped gradients . Magn Reson Imag 1994; 12: 1205-1225 .

21.

Tkac I , Starcuk Z , Choi IY , Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time . Magn Reson Med 1999; 41: 649-656 .

22.

Pijnapel WWF , Van den Boogart A , De Beer RD , Van Ordmond . SVD-based quantification of magnetic resonance signal . J Magn Reson 1992; 97: 122-134 .

23.

Vanhamme L , Van den Boogart A , Von Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge . J Magn Reson 1997; 129: 35-43 .

24.

Pozzilli C et al. No differences in corpus callosum size by sex and aging. A quantitative study using magnetic resonance imaging . J Neuroimag 1994; 4: 218-221 .

25.

Leary SM et al. A1H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis . Magn Reson Imag 2000; 18: 455-459 .

26.

Pandya DN , Karol EA , Heibronn D. The topographical distribution of interhemispheric projections in the corpus callosum of the rhesus monkey . Brain Res 1971; 32: 31-43 .

27.

De Lacoste MC , Kirkpatrick JB , Ross ED. Topography of the human corpus callosum . J Neuropathol Exp Neurol 1985; 44: 578-591 .

28.

Risse GL et al. Interhemispheric transfer in patient with incomplete section of the corpus callosum: anatomic verification with magnetic resonance imaging . Arch Neurol 1989; 46: 437-443 .

29.

Gazzaniga MS , Freedman H. Observations on visual processes after posterior callosal section . Neurology 1973; 23: 1126-1130 .

30.

Clarke S , Miklossy J. Occipital cortex in man: organization of callosal connection, related myelo- and cytoarchitecture, and putative boundaries of functional visual areas . J Comp Neurol 1990; 298: 188-214 .

31.

Funnell MG , Corballis PM , Gazzaniga MS. Insights into the functional specificity of the human corpus callosum . Brain 2000; 123: 920-926 .

32.

Rothman DL et al. In vivo nuclear magnetic resonance spectroscopy sudies of the relationship between the gluta-mate-glutamine neurotransmitter cycle and functional neuroenergetics . Philos Trans R Soc Lond B Biol Sci 1999; 354: 1165-1177 .

33.

Chard DT et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsingremitting multiple sclerosis . Brain 2002; 125: 2342-2352 .

34.

Davies SE et al. High resolution proton NMR spectroscopy of multiple sclerosis lesions . J Neurochem 1995; 64: 742-748 .

35.

Bitsch A et al. inflammatory demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy . AJNR Am J Neuroradiol 1999; 20: 1619-1627 .

36.

De Stefano N et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability . Arch Neurol 2001; 58: 65-70 .

37.

Allen IV , McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis . J Neurol Sci 1979; 41: 81-91 .

38.

Filippi M et al. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging . Arch Neurol 2000; 57: 1017-1021 .

39.

Rocca MA et al. Weekly diffusion-weighted imaging of normal appearing white matter in MS . Neurology 2000; 55: 882-884 .

40.

Filippi M et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis . Ann Neurol 1998; 43: 809-814 .

41.

Filippi M. Magnetization transfer imaging to monitor the evolution of individual multiple sclerosis lesions . Neurology 1999; 53(Suppl 3): S18-S22 .

42.

Cercignani M et al. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI . Neurology 2000; 54: 1139-1144 .

43.

Koenig SH. Cholesterol of myelin is the determinant of grey-white contrast in MRI of brain . Magn Reson Med 1991; 20: 285-291 .

44.

Edzes HT , Samulski RT. Cross-relaxation and spin diffusion in the proton NMR of hydrated collagen . Nature 1977; 265: 521-523 .

45.

Van Buchem MA et al. Magnetization transfer histogram methodology: its clinical and neuropsychological correlates . Neurology 1999; 53: S23-S28 .

46.

Kucharczyk W et al. Relaxivity and magnetization transfer of white matter lipids at MR imaging: importance of cerebrosides an pH . Radiology 1994; 192: 521-529 .

47.

Sarchielli P et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients . Brain 1999; 122: 513-521 .

48.

De Stefano N et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study . Brain 1998; 121: 1469-1477 .

49.

Leary SM et al. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis . J Neurol 1999; 246: 1023-1026 .

50.

Gonen O et al. Total brain N-acetylaspartate. A new measure of disease load in MS . Neurology 2000; 54: 15-19 .

51.

Brex PA et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis . J Neurol Sci; 166: 16-22 .

52.

Tartaglia MC et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis . J Neurol 2002; 249: 1382-1390 .

53.

Schmierer K , Niehaus L , Röricht S , Meyer BU. Conduction deficits of callosal fibers in early multiple sclerosis . J Neurol Neurosurg Psychiatry 2000; 68: 633-638 .